ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Clinical trials for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) trials appear
Sign up with your email to follow new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Massive study tests Weight-Loss Drug's power to prevent heart attacks and death
Disease control CompletedThis large, completed study looked back at health records of over 285,000 overweight or obese adults to see if taking the weekly medication semaglutide was linked to fewer serious heart problems. It focused on three groups: people with existing heart failure, people with heart ar…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Prostate drug may shield Men's hearts
Prevention CompletedThis study looked at whether medications commonly used for enlarged prostate (BPH) might also help prevent heart disease. Researchers analyzed health records from 10,000 men with BPH to see if those taking the prostate drugs had fewer heart problems. The goal was to find out if t…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Sponsor: Chinese PLA General Hospital • Aim: Prevention
Last updated Apr 03, 2026 14:42 UTC
-
Doctors polled on hidden inflammation link between heart and kidney disease
Knowledge-focused CompletedThis study surveyed 1500 heart and kidney doctors in China. The goal was to understand their awareness and views on the role of body-wide inflammation in patients who have both heart and kidney disease. The survey asked about how doctors identify and manage this inflammation in t…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC